Centessa Pharmaceuticals 宣布公开发行 1 亿美元 ADS，由高盛和 Leerink Partners 领投，并设有 30 天的承销商选择权。 Centessa Pharmaceuticals announces a $100m public offering of ADSs, led by Goldman Sachs and Leerink Partners, with a 30-day underwriter option.
临床阶段制药公司 Centessa Pharmaceuticals 宣布公开发行 1 亿美元美国存托股票 (ADS)，每股代表一股普通股。 Centessa Pharmaceuticals, a clinical-stage pharmaceutical firm, announces a $100 million public offering of American Depositary Shares (ADSs), each representing one ordinary share. 此次发行由高盛和 Leerink Partners 牵头，还包括承销商在 30 天内购买额外 1500 万美元的选择权。 The offering, led by Goldman Sachs and Leerink Partners, also includes a 30-day option for underwriters to purchase an additional $15 million. 该提议取决于市场情况，并且不保证发行的完成或条款。 The proposal is contingent on market conditions and no assurance is given on the completion or terms of the offering.